The role of intellectual property in biotechnology

Author： Thomas S.M.  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.7, Iss.9, 1997-09, pp. : 929-936

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intellectual property rights helping limit drug accessibility

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 581, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Intellectual property rights divide India and the USA

By  

Reproductive BioMedicine Online, Vol. 11, Iss. 1, 2005-07 ,pp. : 70-70

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

siRNA as a new drug: intellectual property

By Schiffelers Raymond M   van Kolfschoten Sarianne C   van Dijk Maarten   Scaria Putthupparampil V   Woodle Martin C   Storm Gert  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 2, 2005-02 ,pp. : 141-152

Informa Healthcare

Access to resources Recommend Favorite

India: intellectual property and HIV therapy for the developing world

By Dionisio Daniele  

Future Virology, Vol. 6, Iss. 1, 2011-01 ,pp. : 1-3

Future Medicine

Access to resources Recommend Favorite

Patentability and maximum protection of intellectual property in proteomics and genomics1

By Warburg Richard J   Wellman Arthur   Buck Todd B   Ligler Schoenhard Amy  

Pharmacogenomics, Vol. 4, Iss. 1, 2003-01 ,pp. : 81-90

Future Medicine

Access to resources Recommend Favorite